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The synthetic drugs developed against dermatophytic infections caused by Trichophyton rubrum are not altogether free of side effects. The therapeutic measures sometimes become toxic to humans. With that in view, extracts from five plants, plentifully available in India, were tested under in vitro conditions upon the variants of T. rubrum causing cutaneous and superficial skin infections at Rourkela, Orissa, India. It was observed that oils of Azadirachta indica, Pongamia glabra and extracts from the rhizomes of Curcuma longa were highly effective in inhibiting the growth of the fungal variants in this part of the world. In this paper, the in vitro minimal inhibiting concentration of these plant extracts were determined against 4 variants of T. rubrum.
Key words : Trichophyton rubrum variants/Plant extracts/Antifungal activity.
The hot, humid conditions of the tropics provide an ideal environment for the development of superficial and cutaneous mycotic infections of the skin which are a fairly common dermatological problem in this area. Among several such mycoses, Trichophyton rubrum is predominantly anthropophilic (Kushida and Watanabe, 1975; Rippon, 1988) . It has been determined by a survey (Das et al, 1995) that in Rourkela, Orissa, India, 4 variants of T. rubrum, cause widespread dermatophytic skin ailments. Although drugs effective against such mycotic infections have already been developed, some plant extracts are of considerable interest because they are relatively free of side effects. The use of medicinal herbs in the treatment of infections is an age-old practice throughout the world (Irobi and Daramula, 1993) . However, the knowledge of pharmacological properties and therapeutic value of plant extracts is still fragmentary (Caceras et al., 1993; Choumont and Burgeois, 1978; Garg and Muller, 1992; leven et al., 1979; Lemos et al., 1990; Mac Rea et al., 1988; Moore et al., 1977; Venugopal and Venugopal, 1994) .
Out of 1230 patients who visited the Ispat General Hospital, Rourkela, Orissa, India, with superficial and cutaneous skin ailments, only 250 were suspected to be cases of dermatomycoses. Of these 96 cases were indentified to be dermatophytes due to the 4 variants of T. rubrum. The variants were classified as Downy, Dysgonic, Granular and a new variant was named here as A variant type. Such cutaneous and superficial skin infections in were called tinea lesions. Depending on the site of infection this nomenclature varied as shown in Table 1 .
In this study, the minimal inhibitory concentration (MIC) of 5 natural plant extracts were determined against variants of T. rubrum in their most suitable growth medium, i. e., Sabouraud's dextrose (SD) broth (the results should supplement the present knowledge on therapeutic methods for prevention of the disease).
The plant extracts were neem oil (Azadirachta indica, Juss) , pongamia oil (Pongamia glabra, Vent), safflower oil (Carthamus tinctorious, Linn), mahul oil (Madhuca indica, J.f) and extract of turmeric (Curcuma longa, L). The oils were obtained from sponsored outlets of the Government of Orissa, India.
The oils and extracts were tested for their antifungal effect on the in vitro growth of the variants of the organism at graded concentrations of 70, 140, 210, Garg and Muller (1993) noted that the oils and extracts of Curcuma can be utilized against a broad of spectrum of pathogenic fungi.
Since the variants of the organism were determined to be anthropophilic, the efficacy of plant extracts could not be tested in vivo on human beings by inducing artificially created infections on them. Further more, in the in vitro MIC dosages of compounds could not be prescribed for use upon the lesions of people visiting hospitals due to obvious legal and ethical grounds. Hence, in vitro experimental results will, no doubt, stimulate in vivo tests to strengthen the assumptions regarding the therapeutic value of the plant extracts.
